A novel insulin mimetic vanadium-flavonol complex: Synthesis, characterization and in vivo evaluation in STZ-induced rats

European Journal of Medicinal Chemistry

Volumn 63, Issue , 2013, Pages 109-117

  Pillai, Subramanian Iyyam ^a   Subramanian, Sorimuthu Pillai ^a   Kandaswamy, Muthusamy ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Diabetes; Flavonol; Insulin mimetic; Spectroscopic analysis; Vanadium

Indexed keywords

ANTIDIABETIC AGENT; FLAVONOL; STREPTOZOCIN; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VANADIUM FLAVONOL COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; IN VIVO STUDY; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BIOMIMETIC MATERIALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOLS; GLUCOSE TOLERANCE TEST; GLYCOGEN; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; MASS SPECTROMETRY; MODELS, CHEMICAL; MOLECULAR STRUCTURE; POTENTIOMETRY; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TREATMENT OUTCOME; VANADIUM;

EID: 84874443857     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.02.002     Document Type: Article

References (42)

1. V. Sabetsky, and J. Ekblom Insulin: a new era for an old hormone Pharmacol. Res. 61 2010 1 4
2. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res. Clin. Pract. 87 2010 4 14
3. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 2010 S62 S69
4. D.M. Nathan, J.B. Buse, M.B. Davidson, R.J. Heine, R.R. Holman, R. Sherwin, and B. Zinman Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes Diabetes Care 29 2006 1963 1972
5. E.R. Jamieson, and S.J. Lippard Structure, recognition and processsing of cisplatin-DNA adducts Chem. Rev. 99 1999 2467 2498
6. S.M. Brichard, and J.C. Henquin The role of vanadium in the management of diabetes Trends Pharmacol. Sci. 16 1995 265 270
7. B. Ramachandran, D.S. Sekar, M. Kandaswamy, V. Narayanan, and S. Subramanian Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats Exp. Diabesity Res. 5 2004 137 142
8. B. Ramachandran, M. Kandaswamy, V. Narayanan, and S. Subramanian Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats Diabetes Obes. Metab. 5 2003 455 461
9. B. Ramachandran, K. Ravi, V. Narayanan, M. Kandaswamy, and S. Subramanian Effect of macrocyclic binuclear oxovanadium complex on tissue defense system in streptozotocin-induced diabetic rats Clin. Chim. Acta 345 2004 141 150
10. B. Ramachandran, K. Ravi, V. Narayanan, M. Kandaswamy, and S. Subramanian Protective effect of macrocyclic binuclear oxovanadium complex on oxidative stress in pancreas of streptozotocin induced diabetic rats Chem. Biol. Interact 149 2004 9 21
11. H.K. Thompson, and C. Orvig Design of vanadium compounds as insulin enhancing agents J. Chem. Soc. Dalton Trans. 2000 2885 2892
12. H. Sakurai, H. Sano, T. Takino, and H. Yasui An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats J. Inorg. Biochem. 80 2000 99 105
13. B.H. Havsteen The biochemistry and medical significance of the flavonoids Pharmacol. Ther. 96 2002 67 202
14. J.P. Cornard, L. Dangleterre, and C. Lapouge DFT and TD-DFT investigation and spectroscopic characterization of the molecular and electronic structure of the Zn(II)-3-hydroxyflavone complex Chem. Phys. Lett. 419 2006 304 308
15. G.S. Prasath, and S.P. Subramanian Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats Eur. J. Pharmacol. 668 2011 492 496
16. T. Venkatesan, and S. Sorimuthu Pillai Antidiabetic activity of gossypin, a pentahydroxyflavone glucoside, in streptozotocin-induced experimental diabetes in rats J. Diabetes 4 2012 41 46
17. V.A. Kostyuk, A.I. Potapovich, E.N. Vladykovskaya, L.G. Korkina, and I.B. Afanas'ev Influence of metal ions on flavonoid protection against asbestos-induced cell injury Arch. Biochem. Biophys. 385 2001 129 137
18. K. Vijayaraghavan, S. Iyyam Pillai, and S.P. Subramanian Design, synthesis and characterization of zinc-3 hydroxyflavone, a novel zinc metallo complex for the treatment of experimental diabetes in rats Eur. J. Pharmacol. 680 2012 122 129
19. A.K. Bordbar, A.L. Creagh, F. Mohammadi, C.A. Haynes, and C. Orvig Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin J. Inorg. Biochem. 103 2009 643 647
20. V.G. Yuen, P. Caravan, L. Gelmini, N. Glover, J.H. McNeill, I.A. Setyawati, Y. Zhou, and C. Orvig Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands J. Inorg. Biochem. 68 1997 109 116
21. K.H. Thompson, B.D. Liboiron, Y. Sun, K.D. Bellman, I.A. Setyawati, B.O. Patrick, V. Karunaratne, G. Rawji, J. Wheeler, K. Sutton, S. Bhanot, C. Cassidy, J.H. McNeill, V.G. Yuen, and C. Orvig Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential J. Biol. Inorg. Chem. 8 2003 66 74
22. P. Caravan, L. Gelmini, N. Glover, F.G. Herring, H. Li, J.H. McNeill, S.J. Rettig, I.A. Setyawati, E. Shuter, Y. Sun, A.S. Tracey, V.G. Yuen, and C. Orvig Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent J. Am. Chem. Soc. 117 1995 12759 12770
23. Mihaela Badea, Rodica Olar, Dana Marinescu, Valentina Uivarosi, Victoria Aldea, and Teodor Octavian Nicolescu Thermal stability of new vanadyl complexes with flavonoid derivatives as potential insulin-mimetic agents J. Therm. Anal. Calorim 99 2010 823 827
24. F. Yang, and D.A. Rice Synthesis and characterisation of cobalt(II) complexes of 3-hydroxyflavone Pertanika J. Sci. Tech. 3 1995 211 219
25. Mihaela Badea, Rodica Olar, Valentina Uivarosi, Dana Marinescu, Victoria Aldea, Stefania Felicia Barbuceanu, and George Mihai Nitulescu Thermal behavior of some vanadyl complexes with flavone derivatives as potential insulin-mimetic agents J. Therm. Anal. Calorim. 105 2011 559 564
26. E.G. Lewars, and R.E. March Fragmentation of 3-hydroxyflavone; a computational and mass spectrometric study Rapid Commun. Mass. Spectrom. 21 2007 1669 1679
27. E. Woźnick, M. Kopacz, M. Umbreit, and J. Kłos New complexes of La(III), Ce(III), Pr(III), Nd(III), Sm(III), Eu(III) and Gd(III) ions with morin J. Inorg. Biochem. 101 2007 774 782
28. J.C. Dutton, G.D. Fallon, and K.S. Murray synthesis, structure, ESR spectra and redox properties of (N, N'-ethylenebis(thiosalicylideneaminato)) oxovanadium(IV) and of related {S, N} chelates of vanadium(IV) Inorg. Chem. 27 1988 34 38
29. J.H. McNeill, V.G. Yuen, H.R. Hoveyda, and C. Orvig Bis(maltolato) oxovanadium(IV) is a potent insulin mimic J. Med. Chem. 35 1992 1489 1491
30. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 50 2001 537 546
31. Y.M. Luijf, J. Hermanides, M.J. Serlie, J.B. Hoekstra, and M.R. Soeters The added value of oral glucose tolerance testing in pre-diabetes Curr. Diabetes Rev. 7 2011 56 60
32. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, R. Sherwin, B. Zinman American Diabetes Association; European Association for the Study of Diabetes Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes Diabetologia 52 2009 17 30
33. S.K. Garg, and H. Ulrich Achieving goal glycosylated hemoglobin levels in type 2 diabetes mellitus: practical strategies for success with insulin therapy Insulin 1 2006 109 121
34. N. Møller, and K.S. Nair Diabetes and protein metabolism Diabetes 57 2008 3 4
35. P.H. Sugden, and S.J. Fuller Regulation of protein turnover in skeletal and cardiac muscle Biochem. J. 273 1991 21 37
36. H. Bräunlich, F. Marx, C. Fleck, and G. Stein Kidney function in rats after 5/6 nephrectomy (5/6 NX); effort of treatment with vitamin E Exp. Toxicol. Pathol. 49 1997 135 139
37. M. van den Brand, L.D. Elving, J.P. Drenth, and J.H. van Krieken Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus Neth. J. Med. 67 2009 394 396
38. M.G. Bischof, M. Krssak, M. Krebs, E. Bernroider, H. Stingl, W. Waldhäusl, and M. Roden Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes Diabetes 50 2001 392 398
39. Origin 8.5 2010 OriginLab Corporation Northampton
40. N. Rakieten, M.L. Rakieten, and M.V. Nadkarni Studies on the diabetogenic action of streptozotocin (NSC-37917) Cancer Chemother. Rep. 29 1963 91 98
41. L.J. Fischer, and D.E. Rickert Pancreatic islet-cell toxicity CRC Crit. Rev. Toxicol. 3 1975 231 263
42. J.H. Roe, and R.E. Dailey Determination of glycogen with the anthrone reagent Anal. Biochem. 15 1966 245 250